维普中文期刊产品整合服务
12篇 您的检索式:作者名="Kafiri"
    题名 作者 年代 出处 被引量
1Primary gastric melanoma: A case report显示文摘为所有恶性瘤的 1-3% 的黑瘤报道。除了皮肤,另外的不太普通的黑瘤包括在其它之中,那些在官方补给的道。然而,他们的主要或第二等的性质经常是困难的建立。指胃,主要黑瘤的散布案例在文学被报导了。我们在胃的窦与一个溃烂的 sub-mucosal 团报导一个人的一个案例,迟钝的上面的腹的疼痛地表明了,恶心,呕吐,疲劳和贫血症。这损害组织学地被证明是黑瘤。临床的详细说明的 A 和实验室调查没在其它地方揭示主要地点。到我们的知识,主要胃的黑瘤的很少的案例被报导了。我们的案例是第四曾经出版了,第一在胃的窦定位了。在如此的损害的原始性质之上的争论仍然坚持。因此,特定的诊断标准被建议了。Emmanuel Eustathios Lagoudianakis Michael Genetzakis Dimitrios Konstantinos Tsekouras Artemisia Papadima Georgia Kafiri Konstantinos Toutouzas Vaggelogiannis Katergiannakis Andreas Manouras 2006World Journal of Gastroenterology2006,12,27:8
2Laparoscopic fenestration of multiple giant biliary mucinous cystadenomas of the liver显示文摘Biliary cystadenomas of the liver are rare, cystic neoplasms of the biliary ductal system usually occur in middle aged women. We report a case of synchronous multiple huge biliary mucinous cystadenomas with unique features. This is, according to our knowledge, the first report in the literature about three synchronously occurring hepatobiliary cystadenomas. Cystadenomas have a strong tendency to recur, particularly following incomplete excision, and a potential of malignant transformation. A therapeutic re-evaluation may be necessary when the diagnosis of hepatobiliary cystadenoma is made after the operation and an open liver resection should be considered.A Manours E Lagoudianakis L Alevizos H Markogiannakis G Kafiri C Bramis K Filis K Toutouzas 2008World Journal of Gastroenterology2008,14,26:2
3Malignant gastrointestinal melanomas of unknown origin: Should it be considered primary?显示文摘TO THE EDITOR We read with interest the article entitled: ‘Jejuno-jejunal invagination due to intestinal melanoma’ by Resta G, et al[1]. They reported a rare clinical case of a young woman with a bleeding jejunal melanoma, whose earlyA Manouras M Genetzakis E Lagoudianakis H Markogiannakis A Papadima G Kafiri K Filis PB Kekis V Katergiannakis 2007World Journal of Gastroenterology2007,13,29:2
4Core variablity dose not affect response to interferon alpha in HBeAg negative chronic hepatitis B显示文摘 Owsianka AM Kafiri G 1997J Hepatol1997,29,:1
5Cytokeratin-7, cytokeratin-19, and c-Kit: Immunoreaction during the evolution stages of primary biliary cirrhosis显示文摘Paschalis Chatzipantelis Andreas C. Lazaris Georgia Kafiri Konstandina Papadimitriou Thomas G. Papathomas Aphrodite Nonni Efstratios S. Patsouris 2006Hepatology Research2006,,3:1
6Cytokeratin-7, cytokeratin-19, and c-Kit: Immunoreaction during the evolution stages of primary biliary cirrhosis显示文摘Paschalis Chatzipantelis Andreas C. Lazaris Georgia Kafiri Konstandina Papadimitriou Thomas G. Papathomas Aphrodite Nonni Efstratios S. Patsouris 2006Hepatology Research2006,,3:1
7Multiple systems organ failure from organophosphate poisoning显示文摘Betrosian A Balla M Kafiri G 1995J Toxicol Clin Toxicol1995,33,3:1
8Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity显示文摘Emmanuel Tsochatzis George V. Papatheodoridis Emilia Hadziyannis Anastasia Georgiou Georgia Kafiri Dina G. Tiniakos Emanuel K. Manesis Athanasios J. Archimandritis 2008Scandinavian Journal of Gastroenterology2008,,9:1
9Sclerosing lymphocytic lobulitis in the male breast显示文摘Lee AH Zafrani B Kafiri G 1996J Clin Pathol1996,49,7:1
10Spontaneous pregnancy and birth of a normal female from a woman with Turner syndrome and elevated gonadotropins显示文摘Livadas S Xekouki P Kafiri G 2005Fertil Steril2005,83,3:1
11Rectal carcmosarcoma: A case report and review of literature显示文摘60 年的老男性为在一些星期持续时间的澄清期间加强的便秘和下腹部的不快的调查进入我们的部门。原因证明了是被腹会阴切除术和手术后的 chemo 放射疗法对待的一个直肠的癌肉瘤。病人 6 个月以后由于肝的失败死了,显示出传播疾病的证据。一般来说结肠的癌肉瘤组成其性质仍然不完全地被理解的恶意的瘤的一个稀罕范畴。没有特异疗法指南存在。外科是治疗的支柱,不管辅助治疗的增加,预后是很差的。系统的基因分析可以是为理解这些神秘肿瘤的致病的线索。Dimitrios Konstantinos Tsekouras Stylianos Katsaragakis Dimitrios Theodorou Georgia Kafiri Fotis Archontovasilis Panagiotis Giannopoulos Panagiotis Drimousis John Bramis 2006World Journal of Gastroenterology2006,12,9:1
12Hepatotoxicity induced by cyproterone acetate:A report of three cases显示文摘Cyproterone acetate (CPA) is a steroidal synthetic progestagen and anti-androgenic compound widely administered in prostate cancer which has been evidentially correlated with a severe hepatotoxic potency. Three male patients aged 78-83 years are presented, in whom severe hepatotoxic reactions emerged after CPA administration. Patients were treated with CPA at the doses of 200-300 mg/d for malignant prostate disease for 3-12 mo prior to the acute manifestation of the hepatic disease. Clinical features compatible with mixed hepatocellular and cholestatic liver disease including jaundice, white stools and dark urine, manifested in all three cases whereas encephalopathy and ascites were present in two of the patients. Other primary causes of hepatotoxicity (alcohol consumption and viral hepatitis) were also verified in two cases, and in those patients biopsy findings revealed the presence of cirrhotic lesions in liver parenchyma. Discontinuation of the therapeutic agent led to the amelioration of the clinical profile in all the patients whereas a patient died 40 d after hospital admission due to sepsis, despite acute liver disease improvement. The current article highlights the hepatotoxic potency of a widely administered therapeutic agent and illustrates the importance of clinical surveillance especially in patients with previous hepatic diseases. Three relevant cases are reported and a review of the published literature is made.Ioanna Savidou Melanie Deutsch Aspasia S Soultati Dimitrios Koudouras Georgia Kafiri Spyridon P Dourakis 2006World Journal of Gastroenterology2006,12,46:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费